Cara Therapeutics (CARA) – Hot Comments
-
Jefferies Reiterates Buy Rating on Cara Therapeutics (CARA); 'New Korsuva "Add-on Payment" Extended to 2027'
-
Cara Therapeutics (CARA) Management Meetings Indicate KALM Data Should Be Positive - Jefferies
-
-
-
-
-
Back to CARA Stock Lookup